Through its investment in PsyLabs, Psyence BioMed has secured: A licensed, owned, and debt-free production operation. Source-level ibogaine supply. Natural psilocybin supply. GMP-compliant ...

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies ...

Hong Kong-based Harbour BioMed on Sunday exercised its warrant to acquire the common stock in Spruce Biosciences Inc. (NASDAQ: SPRB). Following this transaction, Harbour BioMed holds approximately 3.8 ...

Before the COVID-19 pandemic, Texas Biomedical Research Institute had established itself as a go-to researcher of infectious diseases, along with therapeutics and vaccines to combat them. It was ...

Corden Pharma Colorado Inc., a developer and manufacturer of peptide drug substances, has leased the 64,000-square-foot 5505 ...

Traditionally, medtech companies have utilized a sales-based model, but many of them are now transitioning to recurring-revenue models like subscription-based services or device-as-a-service. The need ...

Lifecore Biomedical shares rose after the company said it signed a master services agreement with a large pharmaceutical customer. The stock rose 12% to $8.62 on Wednesday. Shares are up 16% this year ...

CordenPharma Colorado is leasing 5505 Central, a newly completed, purpose-built peptide development lab at Flatiron Park in Boulder (US). Photo credit: CordenPharma Photo ...

BridgeBio Pharma sees its Relative Strength Rating move into the elite 90-plus level.

New Haven, Conn.-based Yale University is partnering with pharmaceutical company Boehringer Ingelheim to launch a Biomedical Data Science Fellowship program aimed at innovating drug discovery. A May ...

Current Pharmaceutical Analysis (CPA) is a distinguished journal in the field of pharmaceutical and biomedical analysis. Published by Far Publishing Company, CPA provides a platform for researchers to ...